Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F22%3A00079199" target="_blank" >RIV/00209805:_____/22:00079199 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/22:00128842

Výsledek na webu

<a href="https://www.sciencedirect.com/science/article/pii/S0923753422018506" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0923753422018506</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.annonc.2022.07.003" target="_blank" >10.1016/j.annonc.2022.07.003</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Popis výsledku v původním jazyce

Oesophageal cancer is the seventh most common cancerworldwide, with 604 000 new cases diagnosed in 2020. It isthe sixth most common cause of cancer-related mortality,with an estimated 544 000 deaths in 2020.1 Approximately70% of oesophageal cancer diagnoses occur in men; there isa twofold to threefold difference in incidence and mortalityrates between the sexes. Rates of oesophageal cancer arehigher in developing versus developed countries for men,but are comparable for women.2 Eastern Asia exhibits thehighest regional incidence, followed by Southern Africa,Eastern Africa, Northern Europe and South Central Asia.1Recent data from the US Surveillance, Epidemiology, andEnd Results database indicate an increased incidence ofoesophageal adenocarcinoma (AC) in patients aged&lt;50 years. In addition, young patients tend to be diagnosed

Název v anglickém jazyce

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Popis výsledku anglicky

Oesophageal cancer is the seventh most common cancerworldwide, with 604 000 new cases diagnosed in 2020. It isthe sixth most common cause of cancer-related mortality,with an estimated 544 000 deaths in 2020.1 Approximately70% of oesophageal cancer diagnoses occur in men; there isa twofold to threefold difference in incidence and mortalityrates between the sexes. Rates of oesophageal cancer arehigher in developing versus developed countries for men,but are comparable for women.2 Eastern Asia exhibits thehighest regional incidence, followed by Southern Africa,Eastern Africa, Northern Europe and South Central Asia.1Recent data from the US Surveillance, Epidemiology, andEnd Results database indicate an increased incidence ofoesophageal adenocarcinoma (AC) in patients aged&lt;50 years. In addition, young patients tend to be diagnosed

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30204 - Oncology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Annals of oncology

ISSN

0923-7534

e-ISSN

1569-8041

Svazek periodika

33

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

13

Strana od-do

992-1004

Kód UT WoS článku

000938788800003

EID výsledku v databázi Scopus

2-s2.0-85137399417